ZYZhencheng Yan

Zhencheng Yan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhencheng Yan has a total of 124 co-authors. Here are the top co-authors by number of shared publications:

  • Hongbo He

    Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Institute of Hypertension, Chongqing, China

    13 shared publications
  • Zhiming Zhu

    Affiliations Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Institute of Hypertension, Chongqing, China, Chongqing Institute for Brain and Intelligence, Chongqing, China

    12 shared publications
  • Qiang Li

    Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Institute of Hypertension, Chongqing, China

    11 shared publications
  • Zhigang Zhao

    Department of Hypertension and Endocrinology Center for Hypertension and Metabolic Diseases Daping Hospital Army Medical University Chongqing Institute of Hypertension Chongqing China

    11 shared publications
  • Daoyan Liu

    Department of Hypertension and Endocrinology Center for Hypertension and Metabolic Diseases Daping Hospital Army Medical University Chongqing Institute of Hypertension Chongqing China

    9 shared publications
  • Tingbing Cao

    Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Chongqing Key Laboratory of Metabolic Vascular Diseases, Daping Hospital, Army Medical University, Chongqing Institute of Hypertension, Chongqing 400042, China

    9 shared publications

Latest Publications

  • Open Access

    The role of arachidonic acid metabolites in the subtype classification and pathogenesis of primary aldosteronism

    by Mei You, Li Li, Xintao Tan, Xiaoli Liu, Lijuan Wang, Tingbing Cao, Bowen Wang, Min Liu, Yue Gao, Qing Zhou, et al.

  • Diagnostic performance of 24-hour urinary aldosterone for primary aldosteronism in patients with or without discontinuation of antihypertensive medications

    by Mei You, Xin Li, Huandong Zhao, Zhongping Bai, Yushuang Liu, Qing Zhou, Qiang Li, Ruomei Yang, Hexuan Zhang, Hongbo He, et al.

    Primary aldosteronism (PA) is the most common form of secondary hypertension. However, its diagnosis is complicated by the need to withdraw interfering antihypertensive medications. Traditionally, 24-h urinary aldosterone (Uald) level measurement is employed as part of the oral sodium loading test to diagnose PA. However, the diagnostic efficacy of 24-h Uald for PA under a usual diet and without drug washout remains unclear. This retrospective study enrolled 583 patients with essential hypertension (EH) and 259 patients with PA, as well as an external validation cohort comprising 157 hypertensive patients. Patients with unilateral PA presented higher 24-h Uald levels than those with bilateral PA. Combination antihypertensive therapy reduced 24-h Uald levels in both EH and PA groups. Receiver operating characteristic curve analysis revealed similar areas under the curve for 24-h Uald diagnosing PA between the off-medication group (0.879, 95% CI = 0.834–0.925) and the on-medication group (0.851, 95% CI = 0.817–0.886). The optimal 24-h Uald cut-offs for PA diagnosis were 9.57 μg (sensitivity 79.4%, specificity 88.6%) in the off-medication group and 8.41 μg (sensitivity 75.8%, specificity 79.4%) in the on-medication group, with closely matched thresholds observed between patients receiving renin-increasing medications (8.52 μg) and those on combined renin-increasing and renin-suppressing therapy (8.39 μg). The diagnostic accuracy of 24-h Uald reached 89.2% in the external validation cohort. Our research indicates that the 24-h Uald test is clinically feasible for diagnosing PA without additional sodium supplementation or drug washout. However, the diagnostic threshold for 24-h Uald should be adjusted downward in patients on medications.


  • Open Access

    Endothelial SIRT3 deficiency predisposes brown adipose tissue to whitening in diet-induced obesity

    by Qing Zhou, Zongshi Lu, Bowen Wang, Yuyan Wang, Li Li, Mei You, Lijuan Wang, Tingbing Cao, Dan Tong, Jie Xiang, et al.

    Endothelial dysfunction and vascular rarefaction are supposed to be secondary to metabolic diseases, while recent evidence has revealed the primary roles of endothelium in initiating and accelerating metabolic disorders. Here, the effects and underlying mechanisms of endothelial SIRT3 in modulating the whitening of BAT during obesity progression were explored. Therefore, mice with global or BAT regional endothelium-specific Sirt3 knockout were constructed and fed with high-fat diet (HFD). The results showed that both global and BAT regional endothelium-specific Sirt3 knockout accelerated diet-induced weight gain, accompanied by glucose intolerance, insulin resistance, and BAT whitening. In vitro results revealed that the inhibition or knockdown of endothelial Sirt3 impeded palmitic acid-induced angiogenesis deficiency, while the overexpression of Sirt3 exhibited the opposite effects. Furtherly, endothelial Sirt3 overexpression ameliorated palmitic acid-induced adipocyte dysfunction and proinflammatory macrophages polarization in a paracrine way. Mechanistically, endothelial SIRT3 deficiency increased the acetylation of fatty acid synthase (FASN), which disturbed the fatty acid metabolism and thus, leading to angiogenesis insufficiency. Moreover, loss of SIRT3 promoted adipocytes dysfunction and proinflammatory macrophage polarization via CASP1-mediated pyroptosis. Endothelial SIRT3 loss contributed to diet-induced BAT whitening and obesity progression and thus, could be a therapeutic target in treating obesity and associated metabolic diseases.


  • Open Access

    Meriones unguiculatus serves as a spontaneous primary aldosteronism rodent model

    by Mei You, Zongshi Lu, Bowen Wang, Min Liu, Qing Zhou, Li Li, Dan Tong, Yu Zhao, Hexuan Zhang, Zhongping Bai, et al.

    Background: Primary aldosteronism (PA) is the most common form of endocrine hypertension. The available animal models of PA rely on gene manipulation, thus fail to duplicate the general pathological process of PA in humans. Meriones unguiculatus (MU) has been reported to possess a large size of adrenal gland and an elevated ability to save water. In this study, we aimed to confirm whether MU can serve as an ideal animal model of PA. Methods: Sprague Dawley rats of the same body weight (SD1) or age (SD2) as MU were used as control groups. Blood pressure and serum aldosterone, renin and electrolyte levels were measured, and the oral salt loading test was used as confirmatory test to compare the inhibition level of the renin angiotensin aldosterone system (RAAS) among the three groups. The expression and distribution of CYP11B2 (aldosterone synthase) were evaluated in the adrenal gland of each group. Results: MU exhibited typical clinical manifestations of PA, including hypertension, hyperaldosteronism, low renin levels and strong sodium retention and potassium excretion abilities. Compared with control groups, the inhibitory effect of a high-sodium diet on the RAAS was milder in MU, accompanied by significant cardiac dysfunction. The protein expression level and distribution area of CYP11B2 were significantly increased in the adrenal gland of MU. Conclusion: The current study reveals that MU could serve as an ideal spontaneous PA model. The increased expression and distribution of CYP11B2 stimulate the excessive aldosterone production in a renin-independent manner, leading to a significant increase in blood pressure in MU.

  • Changes in thyroid hormones predict weight regain in patients with obesity who undergo metabolic surgery

    by Yi Tang, Wei Liu, Wuhao Wang, Huandong Zhao, Zongshi Lu, Qiang Li, Zhencheng Yan, Hongbo He, Zhigang Zhao, Zhigang Ke, et al.

    Aim: To investigate the relationship between thyroid function and weight regain in patients with obesity after metabolic surgery. Methods: This retrospective study enrolled 162 patients who underwent metabolic surgery. Correlations between decreases in thyroid hormone levels and changes in weight, waist circumference (WC) and the Chinese visceral adiposity index (CVAI) were assessed. Binary logistic regression and receiver operating characteristic (ROC) curves were used to identify predictors and clinically useful cut‐off values, respectively. Results: The levels of thyroid‐stimulating hormone (TSH) and free triiodothyronine (FT3) decreased markedly at 1 year after surgery, as did weight, body mass index (BMI), triglycerides, total cholesterol, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, WC and CVAI. Decreases in TSH and FT3 after metabolic surgery were associated with changes in weight, BMI and CVAI. Binary logistic regression and ROC curve analyses confirmed that decreases in TSH can predict good weight loss after metabolic surgery to some extent. Finally, binary logistic regression and ROC curve analyses confirmed that changes in TSH can predict weight regain after metabolic surgery. Conclusions: Changes in TSH and FT3 after metabolic surgery were correlated with changes in weight and CVAI. Changes in thyroid hormones can predict weight regain in patients with obesity who underwent metabolic surgery.


  • Open Access

    Mitochondrial dysfunction caused by SIRT3 inhibition drives proinflammatory macrophage polarization in obesity

    by Qing Zhou, Yuyan Wang, Zongshi Lu, Bowen Wang, Li Li, Mei You, Lijuan Wang, Tingbing Cao, Yu Zhao, Qiang Li, et al.

    Objective: Metabolic reprogramming is a main feature of proinflammatory macrophage polarization, a process that leads to inflammation in dysfunctional adipose tissue. Therefore, the study aim was to explore whether sirtuin 3 (SIRT3), a mitochondrial deacetylase, participates in this pathophysiological process.Methods: Macrophage‐specific Sirt3 knockout (Sirt3‐MKO) mice and wild‐type littermates were treated with a high‐fat diet. Body weight, glucose tolerance, and inflammation were evaluated. Bone marrow–derived macrophages and RAW264.7 cells were treated with palmitic acid to explore the mechanism of SIRT3 on inflammation.Results: The expression of SIRT3 was significantly repressed in both bone marrow–derived macrophages and adipose tissue macrophages in mice fed with a high‐fat diet. Sirt3‐MKO mice exhibited accelerated body weight and severe inflammation, accompanied with reduced energy expenditure and worsened glucose metabolism. In vitro experiments showed that SIRT3 inhibition or knockdown exacerbated palmitic acid–induced proinflammatory macrophage polarization, whereas SIRT3 restoration displayed opposite effects. Mechanistically, SIRT3 deficiency resulted in hyperacetylation of succinate dehydrogenase that led to succinate accumulation, which suppressed the transcription of Kruppel‐like factor 4 via increasing histone methylation on its promoter, thus evoking proinflammatory macrophages.Conclusions: This study emphasizes an important preventive role of SIRT3 in macrophage polarization and implies that SIRT3 is a promising therapeutic target for obesity.


  • Cx43 acts as a mitochondrial calcium regulator that promotes obesity by inducing the polarization of macrophages in adipose tissue

    by Qing Zhou, Yuyan Wang, Zongshi Lu, Chengkang He, Li Li, Mei You, Lijuan Wang, Tingbing Cao, Yu Zhao, Qiang Li, et al.


  • Open Access

    Quantitative model for assessment of lower‐extremity perfusion in patients with diabetes

    by Qian Zhang, Xiaoxiao Liu, Qiang Li, Yushuang Liu, Hongbo He, Kaifa Wang, Zhencheng Yan

    BackgroundAlthough diabetic and atherosclerotic vascular diseases have different pathophysiological mechanisms, the screening methods currently used for diabetic lower-extremity vascular diseases are mainly based on the evaluation methods used for atherosclerotic vascular diseases. Thus, assessment of microvascular perfusion is of great importance in early detection of lower-extremity ischemia in diabetes. PurposeThis cross-sectional study aimed to develop a quantitative model for evaluating lower-extremity perfusion. MethodsWe recruited 57 participants (14 healthy participants and 43 diabetes patients, of which 16 had lower-extremity arterial disease [LEAD]). All participants underwent technetium-99 m sestamibi (99mTc-MIBI) scintigraphy and ankle-brachial index (ABI) examination. We derived two key perfusion kinetics indices named activity perfusion index (API) and basal perfusion index (BPI). This study was registered in ClinicalTrials.gov (URL: , NCT02752100). ResultsThe estimated limb perfusion values in our lower-extremity perfusion assessment (LEPA) model showed excellent consistency with the actual measured data. Diabetes patients showed reduced lower-extremity perfusion in comparison with the control group (BPI: 106.21 +/- 11.99 vs. 141.56 +/- 17.38, p < 0.05; API: 12.34 +/- 3.27 vs. 14.56 +/- 3.12, p < 0.05). Using our model, the reductions in lower-extremity perfusion could be detected early in approximately 96.30% of diabetes patients. Patients with LEAD showed more severe reductions in lower-extremity perfusion than diabetes patients without LEAD (BPI: 47.85 +/- 20.30 vs. 106.21 +/- 11.99, p < 0.05; API: 7.06 +/- 1.70 vs. 12.34 +/- 3.27, p < 0.05). Discriminant analysis using API and BPI could successfully screen all diabetes patients with LEAD with a sensitivity of 100% and specificity of 80.77%. ConclusionsWe established a LEPA model that could successfully assess lower-extremity microvascular perfusion in diabetes patients. This model has important application value for the recognition of early-stage LEAD in patients with diabetes.


  • Open Access

    Cx43 acts as a mitochondrial calcium regulator that promotes obesity by inducing macrophages polarization

    by Qing Zhou, Yuyan Wang, Zongshi Lu, Chengkang He, Li Li, Mei You, Lijuan Wang, Tingbing Cao, Yu Zhao, Qiang Li, et al.

    Background/Objectives: Metabolic reprogramming initiates pro-inflammatory macrophages polarization that exacerbates adipocyte dysfunction and subsequent obesity. We hypothesize that connexin 43 (Cx43), a widely-expressed gap junction protein, might affect obesity by regulating mitochondrial calcium that participate in macrophage polarization. Subjects/Methods: Macrophage specific knockout of Cx43 and their wild-type littermates were fed with high fat diet (HFD) for 16 weeks. The body weight, glucose homeostasis, and inflammation were evaluated. RAW264.7, the murine-derived cell line, were used and treated with palmitic acid (PA) to mimic the obesity environment. Results: HFD treatment induced obesity and exacerbated macrophages infiltration with upregulation of macrophages Cx43. Macrophage-specific knockout of Cx43 reduced HFD-induced obesity by alleviating inflammation in adipose tissue, with less M1 pro-inflammatory macrophage polarization. In consistence, inhibition or knockdown of Cx43improved the impaired oxidative phosphorylation (OXPHOS), reduced mitochondria-associated membranes (MAM) and mitochondrial Ca2+ overload in response to PA. Mechanistically, we confirmed an interaction between Cx43 and the mitochondrial Ca2+ uniporter (MCU), and knockdown of Cx43 alleviated PA-induced succinate dehydrogenase (SDH) oxidation by lowering MCU-mediated mitochondrial Ca2+ uptake. Conclusions: Cx43 as a mitochondrial Ca2+ regulator that aggravates obesity via promoting macrophages polarized to M1 pro-inflammatory phenotype and suggests that Cx43 might be a promising therapeutic target antagonizing obesity.

  • Open Access

    Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease

    by Mei You, Yushuang Liu, Bowen Wang, Li Li, Hexuan Zhang, Hongbo He, Qing Zhou, Tingbing Cao, Lijuan Wang, Zhigang Zhao, et al.

    Background: Altered adipokine secretion in dysfunctional adipose tissue facilitates the development of atherosclerotic diseases including lower extremity peripheral artery disease (PAD). Asprosin is a recently identified adipokine and displays potent regulatory role in metabolism, but the relationship between asprosin and lower extremity PAD remains uninvestigated. Methods: 33 type 2 diabetes mellitus (T2DM) patients (DM), 51 T2DM patients with PAD (DM + PAD) and 30 healthy normal control (NC) volunteers were recruited and the blood samples were collected for detecting the circulatory asprosin level and metabolomic screening. RNA sequencing was performed using the aorta tissues from the type 2 diabetic db/db mice and human umbilical vein endothelial cells (HUVECs) were treated with asprosin to determine its impact on the endothelial-to-mesenchymal transition (EndMT). Results: The circulating levels of asprosin in DM + PAD group were significantly higher than that of NC group and the DM group. Circulating asprosin level was remarkably negatively correlated with ankle-brachial index (ABI), even after adjusting for age, sex, body mass index (BMI) and other traditional risk factors of PAD. Logistic regression analysis revealed that asprosin is an independent risk factor for PAD and receiver-operator characteristic (ROC) curve determined a good sensitivity (74.5%) and specificity (74.6%) of asprosin to distinguish PAD. Data from metabolomics displayed a typical characteristics of de novo amino acid synthesis in collagen protein production by myofibroblasts in patients with PAD and activation of TGF-β signaling pathway appeared in the aortic tissue of db/db mice. Asprosin directly induces EndMT in HUVECs in a TGF-β-dependent manner as TGF-β signaling pathway inhibitor SB431542 erased the promotional effect of asprosin on EndMT. Conclusions: Elevated circulatory asprosin level is an independent risk factor of lower extremity PAD and might serve as a diagnostic marker. Mechanistically, asprosin directly induces EndMT that participates in vascular injury via activation of TGF-β signaling pathway. Trial registration This trial was registered at clinicaltrials.gov as NCT05068895